BMO Capital Upgrades Abbvie (ABBV) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St rises as yields ease, Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
IMS Releases Gilead (GILD), AbbVie (ABBV) Weekly HCV Data
April 10, 2015 9:14 AM EDTGilead Sciences (NASDAQ: GILD) Harvoni TRx for the week ending April 3 was 9795, down 3% week-over-week, according to RBC Capital analyst Michael J. Yee, citing IMS data. Yee noted April 3 was a holiday. NRx was 3799, down 5%. Harvoni+Sovaldi TRx clocked in at 11711, down 3%, while Harvoni+Sovaldi NRx... More
